All changes between single mAb and control mAb did not reach statistical significance.
← all excerpts
Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer.
1
—
—
All changes between single mAb and control mAb did not reach statistical significance.